Sort
64,565 grants matching “drug discovery”
Mitofusin 2 as a Nodal Regulator of Mitochondrial Function in Cardiomyopathy
$951,300Gerald W. Dorn · Medical University Of South Carolina · R35 · FY2025 · HL
Northeast Node of the National Drug Abuse Clinical Trials Network
$951,169Lisa A Marsch · Dartmouth College · UG1 · FY2019 · DA
Accelerated molecular probe pipeline
$951,168Gerard A Cangelosi · Seattle Biomedical Research Institute · U01 · FY2011 · AI
Peroxynitrate neutralizing agents for stroke therapy
$951,125Inotek Pharmaceuticals Corporation · R44 · FY2003 · NS
Targeting Epigenetic Circuits in B-Cell Lymphomas
$951,038Ari M. Melnick · Weill Medical Coll Of Cornell Univ · R35 · FY2023 · CA
Targeting 15-Prostaglandin Dehydrogenase (15-PGDH) in Cancer Risk, Prevention, and Treatment
$951,000Sanford D Markowitz · Case Western Reserve University · R35 · FY2021 · CA
Targeting 15-Prostaglandin Dehydrogenase (15-PGDH) in Cancer Risk, Prevention, and Treatment
$951,000Sanford D Markowitz · Case Western Reserve University · R35 · FY2017 · CA
Targeting 15-Prostaglandin Dehydrogenase (15-PGDH) in Cancer Risk, Prevention, and Treatment
$951,000Sanford D Markowitz · Case Western Reserve University · R35 · FY2018 · CA
Targeting 15-Prostaglandin Dehydrogenase (15-PGDH) in Cancer Risk, Prevention, and Treatment
$951,000Sanford D Markowitz · Case Western Reserve University · R35 · FY2020 · CA
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer
$950,923Mary Christine Playdon · University Of Utah · U01 · FY2023 · CA
Lung fibrosis modeling and compound testing platform using fibrotic lung ECM that recreates the fibrotic disease environment to improve predictiveness and accelerate anti-fibrotic drug development
$950,532John David O'Neill · Xylyx Bio, Inc. · R44 · FY2022 · HL
Pathway Discovery and Target Validation for Outgrowth of Breast Cancer Metastases
$950,528Joel S. Bader · Johns Hopkins University · U01 · FY2019 · CA
Host and viral genomic determinants of HIV latent reservoir size and characteristics in individuals with substance use disorders
$950,298Robert F Siliciano · Johns Hopkins University · R61 · FY2018 · DA
SBIR Phase II: Removing the Purification Bottleneck in Biopharmaceutical Production
$949,999Bob Snyder · Proteios Technology, Inc. · · FY2020 · TIP
GenePattern and GenePattern Notebook: Integrative 'Omic Analysis for Cancer Research
$949,808Jill P. Mesirov · University Of California, San Diego · U24 · FY2020 · CA
MGNet Administrative Core
$949,582Henry J Kaminski · George Washington University · U54 · FY2021 · NS
PORPHYRINS AS MICROBICIDES FOR PREVENTION OF STDS/HIV
$949,462Emory University · P01 · FY2002 · AI
Genetic Determinants of Epilepsy in Murine Systems
$949,189Wayne N. Frankel · Columbia University Health Sciences · R01 · FY2022 · NS
Common Stem Cell of Origin for Junctional and Gastric Adenocarcinoma
$949,184Frank D. McKeon · Wake Forest University Health Sciences · R01 · FY2025 · CA
Common Stem Cell of Origin for Junctional and Gastric Adenocarcinoma
$949,184Frank D. McKeon · University Of Houston · R01 · FY2022 · CA
Simple DNA/RNA Probes for Protein Targets
$949,182Philip N Borer · Aptamatrix, Inc. · R44 · FY2010 · AI
Aquisition of a Orbitrap IQ-X Mass Spectrometer System with Vanquish Flex UHPLC System for Nucleic Acid Adductomics
$949,116Marcus Stanley Cooke · University Of South Florida · S10 · FY2024 · OD
Pediatric Oncology Clinical Research Training Program
$949,109Susan M Blaney · Baylor College Of Medicine · K12 · FY2019 · CA
Development Of Theoretical Methods For Studying Biological Macromolecules
$948,837Bernard R Brooks · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
CTRIP: Treatment of Sickle Cell Crisis with inhibitors of NKT cell activation
$948,786David G. Nathan · Dana-Farber Cancer Inst · RC2 · FY2010 · HL